1-3 of 3
Wing Yen Wong, MD
Close
Sort by
Journal Articles

Pharmacokinetics, Efficacy and Safety of BAX326, a Novel Recombinant Factor IX: A Prospective, Controlled, Multicenter Study in Previously Treated Patients with Severe (FIX Level < 1%) or Moderately Severe (FIX Level ≤ 2%) Hemophilia B.

Jerzy Windyga, MD, PhD, Toshko Lissitchkov, MD, PhD, Oleksandra Stasyshyn, MD, Vasily Mamonov, MD, Luminita Rusen, MD, PhD, José Luis Lamas, MD, Myungshin Oh, PhD, Miranda Chapman, Sandor Fritsch, PhD, Borislava G Pavlova, PhD, Wing Yen Wong, MD, Brigitt E. Abbuehl, MD
Journal: Blood
Blood (2012) 120 (21): 2222.
https://doi.org/10.1182/blood.V120.21.2222.2222
Published: 2012
Journal Articles

Detection of Non Inhibitory Binding Antibodies to Von Willebrand Factor Affecting the Clearance of VWF:Ag in Von Willebrand Disease

Tobias M Suiter, MD, Pier Mannuccio Mannucci, MD, Christine L Kempton, MD, MSc, Michael Laffan, MD, Edward H Romond, MD, Amy D. Shapiro, MD, Ingvild Birschmann, MD, PhD, Margaret V. Ragni, MD, MPH, Joan Cox Gill, MD, Thynn Thynn Yee, MD, MSc, FRCP, Robert Klamroth, MD, PhD, Frank M Horling, PhD, Birgit M Reipert, PhD, Peter L Turecek, PhD, Katalin Varadi, PhD, Miranda Chapman, Werner Engl, PhD, Wing Yen Wong, MD, Bruce M. Ewenstein, MD PhD, rhVWF Study Team
Journal: Blood
Blood (2011) 118 (21): 2275.
https://doi.org/10.1182/blood.V118.21.2275.2275
Published: 2011
Journal Articles

Successful Use of Argatroban in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin.

Wendy Y. Tcheng, MD, Wing-Yen Wong, MD
Journal: Blood
Blood (2004) 104 (11): 4085.
https://doi.org/10.1182/blood.V104.11.4085.4085
Published: 2004